company background image
4743 logo

Oneness Biotech TPEX:4743 Stock Report

Last Price

NT$86.20

Market Cap

NT$41.2b

7D

-3.1%

1Y

-53.5%

Updated

21 Dec, 2024

Data

Company Financials +

Oneness Biotech Co., Ltd.

TPEX:4743 Stock Report

Market Cap: NT$41.2b

4743 Stock Overview

Engages in the research, development, and sale of new drugs, pharmaceuticals, and health products in Taiwan. More details

4743 fundamental analysis
Snowflake Score
Valuation0/6
Future Growth2/6
Past Performance0/6
Financial Health6/6
Dividends0/6

Rewards

Revenue is forecast to grow 98.27% per year

Risk Analysis

Currently unprofitable and not forecast to become profitable over the next 3 years

Does not have meaningful revenue (NT$112M)


My Notes

Capture your thoughts, links and company narrative

Oneness Biotech Co., Ltd. Competitors

Lotus Pharmaceutical

TWSE:1795

NT$69.1b

YungShin Global Holding

TWSE:3705

NT$14.4b

ScinoPharm Taiwan

TWSE:1789

NT$17.1b

TTY Biopharm

TPEX:4105

NT$18.1b

Price History & Performance

Summary of share price highs, lows and changes for Oneness Biotech
Historical stock prices
Current Share PriceNT$86.20
52 Week HighNT$192.39
52 Week LowNT$85.50
Beta1.66
1 Month Change-17.90%
3 Month Change-40.55%
1 Year Change-53.47%
3 Year Change-64.12%
5 Year Change224.84%
Change since IPO579.89%

Recent News & Updates

Recent updates

Announcing: Oneness Biotech (GTSM:4743) Stock Soared An Exciting 936% In The Last Three Years

Mar 01
Announcing: Oneness Biotech (GTSM:4743) Stock Soared An Exciting 936% In The Last Three Years

Shareholder Returns

4743TW PharmaceuticalsTW Market
7D-3.1%-0.01%-2.1%
1Y-53.5%-2.7%25.6%

Return vs Industry: 4743 underperformed the TW Pharmaceuticals industry which returned -2.7% over the past year.

Return vs Market: 4743 underperformed the TW Market which returned 25.6% over the past year.

Price Volatility

Is 4743's price volatile compared to industry and market?
4743 volatility
4743 Average Weekly Movement5.5%
Pharmaceuticals Industry Average Movement3.7%
Market Average Movement4.4%
10% most volatile stocks in TW Market7.8%
10% least volatile stocks in TW Market2.1%

Stable Share Price: 4743 has not had significant price volatility in the past 3 months compared to the TW market.

Volatility Over Time: 4743's weekly volatility (5%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
2008n/aShuling Chengwww.onenessbio.com

Oneness Biotech Co., Ltd. engages in the research, development, and sale of new drugs, pharmaceuticals, and health products in Taiwan. It operates through New Drug Research and Development, and Agricultural Products Cultivation segments. The company develops ON101, which is in Phase III clinical trials for treating chronic diabetic foot ulcers; and OB318, an anti-cancer drug that is in Phase I clinical trials.

Oneness Biotech Co., Ltd. Fundamentals Summary

How do Oneness Biotech's earnings and revenue compare to its market cap?
4743 fundamental statistics
Market capNT$41.16b
Earnings (TTM)-NT$1.26b
Revenue (TTM)NT$112.20m

366.8x

P/S Ratio

-32.7x

P/E Ratio

Is 4743 overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
4743 income statement (TTM)
RevenueNT$112.20m
Cost of RevenueNT$49.12m
Gross ProfitNT$63.08m
Other ExpensesNT$1.32b
Earnings-NT$1.26b

Last Reported Earnings

Sep 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)-2.64
Gross Margin56.22%
Net Profit Margin-1,121.83%
Debt/Equity Ratio0%

How did 4743 perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/21 05:04
End of Day Share Price 2024/12/20 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Oneness Biotech Co., Ltd. is covered by 6 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Yenya KuoCapital Securities Corporation
Jianzheng WuCapital Securities Corporation
Regina LeeJih Sun Securities Investment Consulting Co., Ltd.